- Alternative therapy
- critical care
- Endocrinology & Metabolism
- GI & liver
- Hospital medicine
- patient satisfaction
- pulmonary medicine
- Reproductive health
Category Archives: Applying evidence
The Bottom Line: Aspirin or non-steroidal anti-inflammatory drugs are standard first-line therapy for acute pericarditis. Acute pericarditis (for complete information, see DynaMed Plus): ibuprofen 600 mg every 8 hours for 1-2 weeks, then taper by 200-440 mg every 1-2 weeks until … Continue reading →
EUH Morning Report: In patients with acute alcoholic hepatitis, does steroid therapy increase the risk of GI bleeding compared to no use of steroids?
The Bottom Line: For patients with acute alcoholic hepatitis, there isn’t literature to answer the question of whether steroid therapy increases risk of GI bleeding compared to no use of steroids. For patients with non-acute alcoholic liver disease who do not have concomitant … Continue reading →
EUH Morning Report: What is the ideal diuretic dosing strategy for diuretics in a patient admitted from home with acute decompensated HF and already on home diuretics?
The Bottom Line: In managing patients admitted with heart failure exacerbation, the DOSE trial confirmed that furosemide (Lasix) intermittent bolus is equivalent to continuous drip, making continuous drip management unnecessary in nearly all situations. Furthermore, symptoms were similar in high dose … Continue reading →
EUH Resident Report: What are the guidelines for prophylaxis for dental procedures in patients with congenital heart disease?
The Bottom Line: Infective endocarditis (IE) prophylaxis for dental procedures should be recommended only for patients with underlying cardiac conditions associated with the highest risk of adverse outcome from IE. For patients with these underlying cardiac conditions, prophylaxis is recommended … Continue reading →
EUH Resident Report: What are indications for anticoagulants for primary prevention of left ventricular thrombosis?
Bottom line: Indications for anticoagulants for primary prevention of left ventricular thrombosis include patients with the following traits: large anterior infarctions (particularly in the anterior location), heart failure, and high embolic risk (including those with echocardiographic evidence of mobile and … Continue reading →
The Bottom Line: The criteria for eligibility for transplantation were the presence of a tumor 5 cm or less in diameter in patients with single hepatocellular carcinomas (HCC) and no more than three tumor nodules, each 3 cm or less … Continue reading →
Evaluation of Guidelines in Syncope Study (EGSYS) syncope score: Calculate by QxMD (app is freely available for Android and Apple devices), EMERG CDRs (app is freely available for Android devices) Osservatorio Epidemiologico sulla Sincope nel Lazio (OESIL) risk score: American … Continue reading →